Hematocrit Within Normal Range With Testosterone Gender-Affirming Therapy

MONDAY, Nov. 27, 2023 -- For people using testosterone as gender-affirming hormone therapy (GAHT), mean hematocrit varies from 41.84 to 45.68 percent, which is within the normal range, according to a study published online Nov. 27 in the Journal of...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news